http://www.pharmaceuticalproductguide.com/blog A comprehensive guide to pharmaceutical products for medical professionals Fri, 11 Jun 2010 09:15:33 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 http://www.pharmaceuticalproductguide.com/blog/2008/03/25/teva-sues-fda-after-denial-of-generic-risperdal-exclusivity/ http://www.pharmaceuticalproductguide.com/blog/2008/03/25/teva-sues-fda-after-denial-of-generic-risperdal-exclusivity/#comments Tue, 25 Mar 2008 15:17:06 +0000 Kimberly O'Brien http://www.pharmaceuticalproductguide.com/blog/2008/03/25/teva-sues-fda-after-denial-of-generic-risperdal-exclusivity/ Teva Pharmaceuticals has filed a lawsuit in a U.S. district court against the FDA after being denied the 180-day exclusivity for its generic version of the blockbuster antipsychotic Risperdal. Teva said that it was eligible for the 180-day marketing exclusivity, as it was the first to submit an abbreviated new drug application (ANDA) for Janssen Pharmaceutical’s Risperdal (risperidone) tablets with a Paragraph IV certification for the ’952 patent.

]]> http://www.pharmaceuticalproductguide.com/blog/2008/03/25/teva-sues-fda-after-denial-of-generic-risperdal-exclusivity/feed/ 0